EC-KG is an interoperable, provenance-first KG which integrates RTX-KG2, ROBOKOP, and PrimeKG at the network-level, encapsulating over 7 million nodes and 81 million edges from 95 primary data sources, and has improved coverage of core biomedical entities, and captures complex biomedical mechanisms within its topology.
Abstract
Identifying causal connections between existing drugs and mechanistic profiles of diseases is a foundational step for effective drug repurposing. Although knowledge graphs (KGs) are highly suited for consolidating biomedical databases and tracking these connections, a single biomedical KG is constrained by its ingestion pipeline and knowledge sources. While different biomedical KGs could be complementary if combined, efforts to combine them into a unified and more comprehensive KG are hindered by lack of interoperability and poor provenance. To address those issues, we present EC-KG, a Biolink Model-compatible KG for computational drug repurposing. EC-KG is an interoperable, provenance-first KG which integrates RTX-KG2, ROBOKOP, and PrimeKG at the network-level, encapsulating over 7 million nodes and 81 million edges from 95 primary data sources. EC-KG has improved coverage of core biomedical entities such as drugs, targets, and diseases relevant to drug repurposing vs source graphs, and captures complex biomedical mechanisms within its topology. We demonstrate that the network unification in EC-KG leads to emergence of novel, mechanistically relevant pathways which are disconnected in the underlying constituent networks and show its applications in method development, benchmarking and predictive drug repurposing applications. EC-KG has already been successfully used in drug repurposing research to surface Botulinum Toxin A as a candidate to treat Major Depressive Disorder, as well as to validate repurposing of Lenalidomide and Dexamethasone for a subgroup of patients with Rosai-Dorfman Disease.
KRAKEN (Knowledge Research & Analysis Kit for Evidence Networks) addresses this gap by integrating existing graphs with specialized sources such as RefMet, LIPID MAPS, NIH Common Data Elements, Polygenic Score Catalog, and derived wellness measures including biological age and biological BMI.
Amy K. Glen, D. Witherington, Trent Leslie et al.· bioRxiv· 0 citations
By unifying fragmented research and enabling robust data exploration, UKB-KG emerges as a powerful tool for advancing biomedical research and driving innovative healthcare applications.
Z. Wang, J. Wang, Y. Shen et al.· medRxiv· 0 citations
DrugReason is proposed, a multi-view reasoning framework that integrates grounded KG reasoning with LLM-generated mechanistic inference for drug repurposing and achieves competitive or superior results compared with graph-based alternatives, while providing interpretable routing-based predictions.
Zi-Jie Liu, Hong-Xuan Li, Zhen Tan et al.· 0 citations
When an ontology-based biomedical knowledge graph (a KG, containing information about genes, pathways, phenotypes, and molecular interactions) is analyzed using a computational reasoning system, the system can return unwanted generic concepts. Such generic concepts, in the context of a query about potential drug treatm...
F. Hodges, Adilbek Bazarkulov, David Koslicki et al.· bioRxiv· 0 citations
Circular RNAs (circRNAs) play critical roles in biological processes and
disease pathogenesis. Knowledge Graphs (KG) excel at integrating heterogeneous biomolecular
data and have become powerful tools for circRNA-disease association prediction. This review
aims to systematically summarize KG-based models, analyze k...
Zhen Shen, Kai-Yang Qu, Si-Guo Wang et al.· Current Bioinformatics· 0 citations
Clinical trial protocols contain critical clinical pharmacology information that is often scattered across different sections of these lengthy documents. The purpose was to evaluate whether a retrieval-augmented generation (RAG) protocol review integrated with knowledge graphs (KGs) could be used to obtain clinical...
Shreyas Waikar, M. Ramanathan· Frontiers in Pharmacology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.